{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28067284", "DateCompleted": {"Year": "2018", "Month": "10", "Day": "29"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "01", "Day": "09"}], "Language": ["eng"], "ELocationID": ["40237", "10.1038/srep40237"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "7", "PubDate": {"Year": "2017", "Month": "Jan", "Day": "09"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Oleanolic acid ameliorates high glucose-induced endothelial dysfunction via PPAR\u03b4 activation.", "Pagination": {"StartPage": "40237", "MedlinePgn": "40237"}, "Abstract": {"AbstractText": ["Oleanolic acid (3\u03b2-hydroxyolean-12-en-28-oic acid, OA) is a pentacyclic triterpenes widely distributed in food, medicinal plants and nutritional supplements. OA exhibits various pharmacological properties, such as hepatoprotective and anti-tumor effects. In this study, we analyzed the effect of OA on endothelial dysfunction induced by high glucose in human vascular endothelial cells (ECs). Western blotting showed that OA attenuated high glucose-reduced nitric production oxide (NO) as well as Akt-Ser<sup>473</sup> and eNOS-Ser<sup>1177</sup> phosphorylation in cultured human umbilical vein ECs (HUVECs). Next, luciferase reporter assay showed that OA activated peroxisome proliferators-activated receptor \u03b4 (PPAR\u03b4) activity. Quantitative reverse transcriptase PCR (qRT-PCR) demonstrated that OA increased the expressions of PPAR\u03b4 target genes (PDK4, ADRP and ANGPTL4) in ECs. Meanwhile, the induced expressions of PDK4, ADRP and ANGPTL4 by OA were inhibited by GSK0660, a specific antagonist of PPAR\u03b4. In addition, inhibition of PPAR\u03b4 abolished OA-induced the Akt-Ser<sup>473</sup> and eNOS-Ser<sup>1177</sup> phosphorylation, and NO production. Finally, by using Multi Myograph System, we showed that OA prevented high glucose-impaired vasodilation. This protective effect on vasodilation was inhibited in aortic rings pretreated with GSK0660. Collectively, we demonstrated that OA improved high glucose-impaired endothelial function via a PPAR\u03b4-mediated mechanism and through eNOS/Akt/NO pathway."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, 710061, China."}], "LastName": "Zhang", "ForeName": "Zihui", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, 710061, China."}], "LastName": "Jiang", "ForeName": "Manli", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, 710061, China."}], "LastName": "Xie", "ForeName": "Xinya", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, 710061, China."}], "LastName": "Yang", "ForeName": "Haixia", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, 710061, China."}], "LastName": "Wang", "ForeName": "Xinfeng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, 710061, China."}], "LastName": "Xiao", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, 710061, China."}, {"Identifier": [], "Affiliation": "The Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044, China."}], "LastName": "Wang", "ForeName": "Nanping", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "PPAR delta"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "6SMK8R7TGJ", "NameOfSubstance": "Oleanolic Acid"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type III"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["toxicity"], "DescriptorName": "Glucose"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Human Umbilical Vein Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type III"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oleanolic Acid"}, {"QualifierName": ["metabolism"], "DescriptorName": "PPAR delta"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Vasodilation"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "de Melo C. L. et al.. Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet. Chemico-biological interactions 185, 59\u201365, doi: 10.1016/j.cbi.2010.02.028 (2010).", "ArticleIdList": ["10.1016/j.cbi.2010.02.028", "20188082"]}, {"Citation": "Lee W., Yang E. J., Ku S. K., Song K. S. & Bae J. S. Anti-inflammatory effects of oleanolic acid on LPS-induced inflammation in vitro and in vivo. Inflammation 36, 94\u2013102, doi: 10.1007/s10753-012-9523-9 (2013).", "ArticleIdList": ["10.1007/s10753-012-9523-9", "22875543"]}, {"Citation": "Jager S., Trojan H., Kopp T., Laszczyk M. N. & Scheffler A. Pentacyclic triterpene distribution in various plants - rich sources for a new group of multi-potent plant extracts. Molecules 14, 2016\u20132031, doi: 10.3390/molecules14062016 (2009).", "ArticleIdList": ["10.3390/molecules14062016", "PMC6254168", "19513002"]}, {"Citation": "Yunoki K. et al.. Effect of dietary wine pomace extract and oleanolic acid on plasma lipids in rats fed high-fat diet and its DNA microarray analysis. Journal of agricultural and food chemistry 56, 12052\u201312058, doi: 10.1021/jf8026217 (2008).", "ArticleIdList": ["10.1021/jf8026217", "19053393"]}, {"Citation": "Madlala H. P. et al.. Vascular Endothelium-Dependent and Independent Actions of Oleanolic Acid and Its Synthetic Oleanane Derivatives as Possible Mechanisms for Hypotensive Effects. PloS one 11, e0147395, doi: 10.1371/journal.pone.0147395 (2016).", "ArticleIdList": ["10.1371/journal.pone.0147395", "PMC4723044", "26799746"]}, {"Citation": "Castellano J. M., Guinda A., Delgado T., Rada M. & Cayuela J. A. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes 62, 1791\u20131799, doi: 10.2337/db12-1215 (2013).", "ArticleIdList": ["10.2337/db12-1215", "PMC3661625", "23704520"]}, {"Citation": "Mudau M., Genis A., Lochner A. & Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovascular journal of Africa 23, 222\u2013231, doi: 10.5830/CVJA-2011-068 (2012).", "ArticleIdList": ["10.5830/CVJA-2011-068", "PMC3721957", "22614668"]}, {"Citation": "Hadi H. A. & Suwaidi J. A. Endothelial dysfunction in diabetes mellitus. Vascular health and risk management 3, 853\u2013876 (2007).", "ArticleIdList": ["PMC2350146", "18200806"]}, {"Citation": "Salimi S. et al.. Association of plasma nitric oxide concentration and endothelial nitric oxide synthase T-786C gene polymorphism in coronary artery disease. Pathophysiology: the official journal of the International Society for Pathophysiology/ISP 19, 157\u2013162, doi: 10.1016/j.pathophys.2012.04.003 (2012).", "ArticleIdList": ["10.1016/j.pathophys.2012.04.003", "22682929"]}, {"Citation": "Bonetti P. O., Lerman L. O. & Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arteriosclerosis, thrombosis, and vascular biology 23, 168\u2013175 (2003).", "ArticleIdList": ["12588755"]}, {"Citation": "Salisbury D. & Bronas U. Reactive oxygen and nitrogen species: impact on endothelial dysfunction. Nursing research 64, 53\u201366, doi: 10.1097/NNR.0000000000000068 (2015).", "ArticleIdList": ["10.1097/NNR.0000000000000068", "25502061"]}, {"Citation": "Siragusa M. & Fleming I. The eNOS signalosome and its link to endothelial dysfunction. Pflugers Archiv: European journal of physiology 468, 1125\u20131137, doi: 10.1007/s00424-016-1839-0 (2016).", "ArticleIdList": ["10.1007/s00424-016-1839-0", "27184745"]}, {"Citation": "Heiss E. H. & Dirsch V. M. Regulation of eNOS enzyme activity by posttranslational modification. Current pharmaceutical design 20, 3503\u20133513 (2014).", "ArticleIdList": ["PMC4401012", "24180389"]}, {"Citation": "Neels J. G. & Grimaldi P. A. Physiological functions of peroxisome proliferator-activated receptor beta. Physiological reviews 94, 795\u2013858, doi: 10.1152/physrev.00027.2013 (2014).", "ArticleIdList": ["10.1152/physrev.00027.2013", "24987006"]}, {"Citation": "Cheang W. S., Tian X. Y., Wong W. T. & Huang Y. The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges. British journal of pharmacology 172, 5512\u20135522, doi: 10.1111/bph.13029 (2015).", "ArticleIdList": ["10.1111/bph.13029", "PMC4667853", "25438608"]}, {"Citation": "Quintela A. M. et al.. PPARbeta activation restores the high glucose-induced impairment of insulin signalling in endothelial cells. British journal of pharmacology 171, 3089\u20133102, doi: 10.1111/bph.12646 (2014).", "ArticleIdList": ["10.1111/bph.12646", "PMC4055208", "24527778"]}, {"Citation": "Tian X. Y. et al.. PPARdelta activation protects endothelial function in diabetic mice. Diabetes 61, 3285\u20133293, doi: 10.2337/db12-0117 (2012).", "ArticleIdList": ["10.2337/db12-0117", "PMC3501853", "22933110"]}, {"Citation": "Howangyin K. Y. & Silvestre J. S. Diabetes mellitus and ischemic diseases: molecular mechanisms of vascular repair dysfunction. Arteriosclerosis, thrombosis, and vascular biology 34, 1126\u20131135, doi: 10.1161/ATVBAHA.114.303090 (2014).", "ArticleIdList": ["10.1161/ATVBAHA.114.303090", "24675660"]}, {"Citation": "Kolluru G. K., Siamwala J. H. & Chatterjee S. eNOS phosphorylation in health and disease. Biochimie 92, 1186\u20131198, doi: 10.1016/j.biochi.2010.03.020 (2010).", "ArticleIdList": ["10.1016/j.biochi.2010.03.020", "20363286"]}, {"Citation": "Mallavadhani U. V. et al.. Three new pentacyclic triterpenes and some flavonoids from the fruits of an Indian Ayurvedic plant Dendrophthoe falcata and their estrogen receptor binding activity. Chemical & pharmaceutical bulletin 54, 740\u2013744 (2006).", "ArticleIdList": ["16651782"]}, {"Citation": "Wang Y. et al.. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma. Molecular endocrinology 14, 1550\u20131556, doi: 10.1210/mend.14.10.0545 (2000).", "ArticleIdList": ["10.1210/mend.14.10.0545", "11043571"]}, {"Citation": "Lee H. K., Nam G. W., Kim S. H. & Lee S. H. Phytocomponents of triterpenoids, oleanolic acid and ursolic acid, regulated differently the processing of epidermal keratinocytes via PPAR-alpha pathway. Experimental dermatology 15, 66\u201373, doi: 10.1111/j.0906-6705.2005.00386.x (2006).", "ArticleIdList": ["10.1111/j.0906-6705.2005.00386.x", "16364033"]}, {"Citation": "Huang T. H. et al.. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. British journal of pharmacology 145, 767\u2013774, doi: 10.1038/sj.bjp.0706245 (2005).", "ArticleIdList": ["10.1038/sj.bjp.0706245", "PMC1576197", "15880139"]}, {"Citation": "Li Y., Qi Y., Huang T. H., Yamahara J. & Roufogalis B. D. Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties. Diabetes, obesity & metabolism 10, 10\u201317, doi: 10.1111/j.1463-1326.2007.00708.x (2008).", "ArticleIdList": ["10.1111/j.1463-1326.2007.00708.x", "18095947"]}, {"Citation": "Ding Y., Yang K. D. & Yang Q. The role of PPARdelta signaling in the cardiovascular system. Progress in molecular biology and translational science 121, 451\u2013473, doi: 10.1016/B978-0-12-800101-1.00014-4 (2014).", "ArticleIdList": ["10.1016/B978-0-12-800101-1.00014-4", "24373246"]}, {"Citation": "Qin X. et al.. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. Hepatology 48, 432\u2013441, doi: 10.1002/hep.22334 (2008).", "ArticleIdList": ["10.1002/hep.22334", "18627005"]}, {"Citation": "Saag K. G. et al.. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357, 2028\u20132039, doi: 10.1056/NEJMoa071408 (2007).", "ArticleIdList": ["10.1056/NEJMoa071408", "18003959"]}, {"Citation": "Ehrenborg E. & Skogsberg J. Peroxisome proliferator-activated receptor delta and cardiovascular disease. Atherosclerosis 231, 95\u2013106, doi: 10.1016/j.atherosclerosis.2013.08.027 (2013).", "ArticleIdList": ["10.1016/j.atherosclerosis.2013.08.027", "24125418"]}, {"Citation": "Rodriguez-Rodriguez R., Herrera M. D., Perona J. S. & Ruiz-Gutierrez V. Potential vasorelaxant effects of oleanolic acid and erythrodiol, two triterpenoids contained in \u2018orujo\u2019 olive oil, on rat aorta. The British journal of nutrition 92, 635\u2013642 (2004).", "ArticleIdList": ["15522132"]}, {"Citation": "Rodriguez-Rodriguez R. et al.. Oleanolic acid induces relaxation and calcium-independent release of endothelium-derived nitric oxide. British journal of pharmacology 155, 535\u2013546, doi: 10.1038/bjp.2008.289 (2008).", "ArticleIdList": ["10.1038/bjp.2008.289", "PMC2579672", "18622409"]}, {"Citation": "Rodriguez-Rodriguez R. Oleanolic acid and related triterpenoids from olives on vascular function: molecular mechanisms and therapeutic perspectives. Curr Med Chem 22, 1414\u20131425 (2015).", "ArticleIdList": ["25515513"]}, {"Citation": "Ding Y., Vaziri N. D., Coulson R., Kamanna V. S. & Roh D. D. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. American journal of physiology. Endocrinology and metabolism 279, E11\u201317 (2000).", "ArticleIdList": ["10893317"]}, {"Citation": "Du X. L. et al.. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. The Journal of clinical investigation 108, 1341\u20131348, doi: 10.1172/JCI11235 (2001).", "ArticleIdList": ["10.1172/JCI11235", "PMC209429", "11696579"]}, {"Citation": "d\u2019Uscio L. V. et al.. Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-delta gene. Am J Physiol Heart Circ Physiol 306, H1001\u20131010, doi: 10.1152/ajpheart.00761.2013 (2014).", "ArticleIdList": ["10.1152/ajpheart.00761.2013", "PMC3962632", "24486511"]}, {"Citation": "Fan Y. et al.. Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells. Arteriosclerosis, thrombosis, and vascular biology 28, 315\u2013321, doi: 10.1161/ATVBAHA.107.149815 (2008).", "ArticleIdList": ["10.1161/ATVBAHA.107.149815", "18048767"]}, {"Citation": "Wang S. et al.. Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension 52, 484\u2013490, doi: 10.1161/HYPERTENSIONAHA.108.112094 (2008).", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.108.112094", "PMC3523107", "18645049"]}, {"Citation": "He T., Smith L. A., Lu T., Joyner M. J. & Katusic Z. S. Activation of peroxisome proliferator-activated receptor-{delta} enhances regenerative capacity of human endothelial progenitor cells by stimulating biosynthesis of tetrahydrobiopterin. Hypertension 58, 287\u2013294, doi: 10.1161/HYPERTENSIONAHA.111.172189 (2011).", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.111.172189", "PMC3143017", "21709207"]}]}], "History": [{"Year": "2016", "Month": "8", "Day": "3"}, {"Year": "2016", "Month": "12", "Day": "2"}, {"Year": "2017", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["28067284", "PMC5220361", "10.1038/srep40237", "srep40237"]}}]}